Could soluble levels of CD40L and galectin-9 be possible prognostic biomarkers and therapeutic targets in NSCLC?
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e21508
Abstract: e21508Background: Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases of lung cancer. The immune system is now recognized to have the potential to destroy cancer cells. T... read more here.
Keywords: levels cd40l; possible prognostic; cd40l galectin; galectin possible ... See more keywords
Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12020336
Abstract: CD163+ M2 macrophages have been suggested to counteract tumor immunity by increasing immunosuppressive mechanisms including PD-L1 and IL-10 expression. Soluble levels of PD-L1, IL-10, and CD163 have been reported as potential biomarkers in various cancers,… read more here.
Keywords: renal cell; soluble levels; cell carcinoma; levels cd163 ... See more keywords